Tirzepatide 1G $695 Private Label

Current Research suggests Tirzepatide offers a dual approach, providing benefits from both GLP and GIP. A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of these incretin hormones to enhance insulin secretion, suppress glucagon release, and slow gastric emptying. This multifaceted approach helps improve blood sugar control, promotes weight loss, and reduces the risk of cardiovascular events in patients with diabetes. Tirzepatide has shown promising results in clinical trials, offering a new therapeutic option for those struggling to achieve glycemic control with existing treatments. Size: 1g Private Label: FDA-registered peptide with B12 API enhanced custom formula, available for rebranding and for commercial distribution with Vitamin B12-100mcg API.  Manufactured with approved DMF according to the Federal Food, Drug, and Cosmetic Act. The NDC number is activated upon order. MINIMUM QUANTITY